Zynex cuts 14% workforce (86 jobs); Tricare payment suspension appeal pending

ZYNEX INC

Reduced workforce by 86 positions (14% of total); expects ~$5M in annualized cost savings.
Severance costs estimated at $0.2M, recognized in Q2 2025, paid in Q2 and Q3 2025.
Tricare temporary payment suspension appeal submitted; no response received to date.
Reduction is part of planned billing strategy adjustment, not related to Tricare suspension.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.